LGVN
Price
$0.54
Change
-$0.01 (-1.82%)
Updated
Feb 4 closing price
Capitalization
11.52M
Intraday BUY SELL Signals
NTLA
Price
$12.36
Change
-$0.69 (-5.29%)
Updated
Feb 4 closing price
Capitalization
1.43B
14 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

LGVN vs NTLA

Header iconLGVN vs NTLA Comparison
Open Charts LGVN vs NTLABanner chart's image
Longeveron
Price$0.54
Change-$0.01 (-1.82%)
Volume$168.75K
Capitalization11.52M
Intellia Therapeutics
Price$12.36
Change-$0.69 (-5.29%)
Volume$4.98M
Capitalization1.43B
LGVN vs NTLA Comparison Chart in %
View a ticker or compare two or three
VS
LGVN vs. NTLA commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LGVN is a StrongBuy and NTLA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (LGVN: $0.54 vs. NTLA: $12.36)
Brand notoriety: LGVN and NTLA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LGVN: 54% vs. NTLA: 99%
Market capitalization -- LGVN: $11.52M vs. NTLA: $1.43B
LGVN [@Biotechnology] is valued at $11.52M. NTLA’s [@Biotechnology] market capitalization is $1.43B. The market cap for tickers in the [@Biotechnology] industry ranges from $119.38B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LGVN’s FA Score shows that 0 FA rating(s) are green whileNTLA’s FA Score has 1 green FA rating(s).

  • LGVN’s FA Score: 0 green, 5 red.
  • NTLA’s FA Score: 1 green, 4 red.
According to our system of comparison, NTLA is a better buy in the long-term than LGVN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LGVN’s TA Score shows that 5 TA indicator(s) are bullish while NTLA’s TA Score has 5 bullish TA indicator(s).

  • LGVN’s TA Score: 5 bullish, 3 bearish.
  • NTLA’s TA Score: 5 bullish, 6 bearish.
According to our system of comparison, LGVN is a better buy in the short-term than NTLA.

Price Growth

LGVN (@Biotechnology) experienced а -9.14% price change this week, while NTLA (@Biotechnology) price change was -10.56% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.41%. For the same industry, the average monthly price growth was +1.41%, and the average quarterly price growth was +32.47%.

Reported Earning Dates

NTLA is expected to report earnings on Feb 19, 2026.

Industries' Descriptions

@Biotechnology (-2.41% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTLA($1.43B) has a higher market cap than LGVN($11.5M). NTLA YTD gains are higher at: 37.486 vs. LGVN (6.680). LGVN has higher annual earnings (EBITDA): -20.98M vs. NTLA (-466.25M). NTLA has more cash in the bank: 511M vs. LGVN (9.24M). LGVN has less debt than NTLA: LGVN (983K) vs NTLA (98M). NTLA has higher revenues than LGVN: NTLA (57.5M) vs LGVN (1.44M).
LGVNNTLALGVN / NTLA
Capitalization11.5M1.43B1%
EBITDA-20.98M-466.25M4%
Gain YTD6.68037.48618%
P/E Ratio2.95N/A-
Revenue1.44M57.5M2%
Total Cash9.24M511M2%
Total Debt983K98M1%
FUNDAMENTALS RATINGS
NTLA: Fundamental Ratings
NTLA
OUTLOOK RATING
1..100
79
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LGVNNTLA
RSI
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
87%
Momentum
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
83%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 11 days ago
83%
Bullish Trend 15 days ago
76%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 1 day ago
87%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
83%
Aroon
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
LGVN
Daily Signal:
Gain/Loss:
NTLA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GEF75.443.07
+4.24%
Greif
LOT1.16N/A
N/A
Lotus Technology
VEEV190.69-0.11
-0.06%
Veeva Systems
NXL0.57N/A
-0.16%
Nexalin Technology
SHIM4.31-0.05
-1.15%
Shimmick Corp

LGVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LGVN has been loosely correlated with ARCT. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if LGVN jumps, then ARCT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LGVN
1D Price
Change %
LGVN100%
-2.30%
ARCT - LGVN
50%
Loosely correlated
+0.14%
NTLA - LGVN
48%
Loosely correlated
-5.29%
TPST - LGVN
47%
Loosely correlated
-1.24%
EDIT - LGVN
45%
Loosely correlated
-5.34%
VTGN - LGVN
44%
Loosely correlated
-3.20%
More

NTLA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NTLA has been closely correlated with CRSP. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if NTLA jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTLA
1D Price
Change %
NTLA100%
-5.29%
CRSP - NTLA
74%
Closely correlated
-3.52%
VCYT - NTLA
69%
Closely correlated
-4.35%
CDXS - NTLA
66%
Closely correlated
-2.94%
VTGN - NTLA
65%
Loosely correlated
-3.20%
BEAM - NTLA
63%
Loosely correlated
-3.37%
More